Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128654) titled 'A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CT... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128680) titled 'Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeuti... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128082) titled 'The Long COVID Treatment Trial' on Aug. 14. Study Type: Interventional Stud... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128667) titled 'Clinical Features and Long-Term Prognosis in Young Patients With Acute Myocard... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128693) titled 'A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combinati... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132112) titled 'GT719 Injection for Moderate to Severe Refractory Autoimmune Disease' on Aug. ... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07133633) titled 'A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyl... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07133685) titled 'Evaluation of Serum IL-7 as a Biomarker in Breast Cancer' on Aug. 14. Study T... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07133828) titled 'A Study to Learn About the Safety of BIIB142 and How it is Processed in the Bo... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130032) titled 'Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizu... Read More